Barclays’s CEL-SCI Corp CVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Hold
0
5315
2025
Q1
Hold
0
5310
2022
Q3
Sell
-26
Closed -$3K 4850
2022
Q2
$3K Sell
26
-175
-87% -$18.2K ﹤0.01% 4842
2022
Q1
$24K Sell
201
-1,254
-86% -$204K ﹤0.01% 4389
2021
Q4
$310K Buy
1,455
+946
+186% +$290K ﹤0.01% 3401
2021
Q3
$168K Buy
509
+247
+94% +$72K ﹤0.01% 3703
2021
Q2
$69K Sell
262
-751
-74% -$465K ﹤0.01% 3983
2021
Q1
$462K Buy
1,013
+650
+179% +$355K ﹤0.01% 3229
2020
Q4
$127K Sell
363
-153
-30% -$60.4K ﹤0.01% 4016
2020
Q3
$197K Sell
516
-2,561
-83% -$1.01M ﹤0.01% 3859
2020
Q2
$1.38M Buy
3,077
+2,710
+738% +$1.11M ﹤0.01% 2458
2020
Q1
$128K Sell
367
-601
-62% -$220K ﹤0.01% 4622
2019
Q4
$266K Buy
968
+521
+117% +$123K ﹤0.01% 4814
2019
Q3
$120K Sell
447
-119
-21% -$27.9K ﹤0.01% 5342
2019
Q2
$142K Buy
+566
New +$102K ﹤0.01% 5403
2018
Q4
Sell
-48
Closed -$6K 6996
2018
Q3
$6K Buy
+48
New +$2.76K ﹤0.01% 6750

Other funds holding CVM

Barclays's CVM Position: Q2 2025 in Review

Barclays held its CEL-SCI Corp (CVM) position steady in Q2 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5315.

Barclays first reported a position in CVM in Q3 2018 and has held it in 14 quarters since. The position peaked at $1.38M in Q2 2020. 28 funds tracked by Wall St. Rank hold CVM as of Q2 2025.

  • Barclays held 0 shares of CEL-SCI Corp worth $0 as of Q2 2025.
  • Barclays left its CEL-SCI Corp share count unchanged in Q2 2025.
  • CEL-SCI Corp made up ﹤0.01% of Barclays's portfolio in Q2 2025, its #5315 holding.
  • Barclays first reported a position in CEL-SCI Corp in Q3 2018 and has held it in 14 quarters since.
  • Barclays's CEL-SCI Corp position peaked at $1.38M in Q2 2020.
  • 28 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.